Sofgen Pharma S.A 20-F for FY2023
Sofgen Pharma S.A. (PROCF)
20-F
2025-09-03
For: 2023-12-31
View Original
Added on
April 06, 2026
About this 20-F
Sofgen Pharma S.A filed this 20-F on September 3, 2025, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $423.75M
- up 5.1% from $403.2M a year earlier
- Net income
- $40.34M
- up 11.7% from net income of $36.13M a year earlier
- Diluted EPS
- $0.40
- up 11.1% from $0.36 a year earlier